Machine Learning Integrating Quantitative MRI and Clinical Features Predicts Loss of Ambulation in Duchenne Muscular Dystrophy.
- 1Department of Radiology, Medical Imaging Center, China Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
- 2Department of Rehabilitation and Department of Pediatric Neurology, China Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
Abstract
Background
Loss of ambulation (LOA) is a key milestone in Duchenne muscular dystrophy (DMD) with highly variable timing, complicating clinical counselling and trial design. Quantitative MRI non-invasively assesses muscle fat infiltration, yet few models have integrated MRI with clinical variables for individualized LOA prediction. We aimed to develop and validate a machine-learning model integrating quantitative MRI and clinical features to predict time to LOA and to derive interpretable, individualized risk estimates and candidate thresholds.Methods
This prospective study enrolled 188 boys with DMD (median age 9.10 years). Quantitative MRI parameters (T1, T2, fat fraction [FF]) of 19 hip/thigh muscles and clinical variables were measured. Patients were randomly split into training (80%) and test (20%) sets. Feature selection used LASSO, Boruta and recursive feature elimination based on random survival forest (RSF). Three survival models were compared: RSF and a ridge-penalised Cox model (both integrating clinical and MRI-derived features) and a multivariable Cox model restricted to clinical variables. Performance was assessed by concordance index (C-index), time-dependent area under the curve (AUC), integrated Brier score (IBS) and decision curve analysis at 12, 24, 36 and 48 months.Results
Over median 43.5 months follow-up, 66 patients (35.1%) experienced LOA. Six predictors were retained: NSAA score, MRC%, age and three FF parameters (rectus femoris, vastus lateralis, obturator internus). In the test set (n = 40, 15 events), RSF achieved a C-index of 0.870 (95% CI, 0.764-0.957), outperforming the clinical Cox (0.804) and ridge Cox (0.853) model. Time-dependent AUCs of the RSF model were 0.984, 0.971, 0.913 and 0.850 at 12, 24, 36 and 48 months. RSF showed the best calibration, with the lowest IBS (0.076, 95% CI: 0.052-0.111), followed closely by the ridge Cox model (0.078) and the clinical Cox model (0.109). RSF stratified patients into low-risk, intermediate-risk and high-risk groups; no LOA events occurred in the low-risk group, with annual event rates were 7.2% and 34.6% in the intermediate- and high-risk groups (log-rank p = 0.0025). SHAP analysis identified exploratory thresholds (NSAA < 14.55, MRC% < 68.36%, rectus femoris FF > 32.30%, vastus lateralis FF > 58.00%, obturator internus FF > 7.43%). An interactive web application enables individualized risk prediction (https://westcndmd-timer-loa-risk-prediction-tool-8cygtrrbykvd9snmfcnhrp.streamlit.app/).Conclusions
A machine-learning-based RSF model integrating quantitative MRI FF metrics and clinical variables exhibited favourable predictive performance for time to LOA in DMD across short- and long-term horizons. It provided interpretable, individualized risk estimates and was deployed as an online tool to support clinical decision-making and trial enrichment.
Related
- Bimodal spectroscopy integrating multi-wavelength time-resolved photoacoustic spectroscopy and near-infrared spectroscopy with deep learning for quantitative detection of serum biochemical indicators
- Multi-cancer screening in peritoneal dialysis patients: an explainable machine learning framework integrating bioelectrical impedance and clinical features
- Deciphering isonicotinylation and mast cell-associated pathogenic patterns in Duchenne muscular dystrophy: evidence from ensemble learning-driven multi-omics and in vitro validation
- 93 Swiss beads calibration enables quantitative quality control for high-dimensional rare-cell mass cytometry in an NIH-supported clinical research workflow
- Artificial Avidity Optimization of T-cell Receptors by Integrating Deep Learning Model and Mammalian Cell Surface Display
BibTeX
@article{liu2026machine,
title = {{Machine Learning Integrating Quantitative MRI and Clinical Features Predicts Loss of Ambulation in Duchenne Muscular Dystrophy.}},
author = {Chuan Liu and Yu Song and Jiayu Wan and Ting Xu and Xinyuan Zhang and Yiqiao Yan and Hang Fu and Xiaotang Cai and Yingkun Guo and Yun Wang and Huayan Xu},
journal = {Journal of cachexia, sarcopenia and muscle},
year = {2026},
month = oct,
doi = {10.1002/jcsm.70413},
url = {https://europepmc.org/article/MED/42913715},
note = {CC BY},
}
RIS
TY - JOUR
TI - Machine Learning Integrating Quantitative MRI and Clinical Features Predicts Loss of Ambulation in Duchenne Muscular Dystrophy.
AU - Chuan Liu
AU - Yu Song
AU - Jiayu Wan
AU - Ting Xu
AU - Xinyuan Zhang
AU - Yiqiao Yan
AU - Hang Fu
AU - Xiaotang Cai
AU - Yingkun Guo
AU - Yun Wang
AU - Huayan Xu
PY - 2026
DA - 2026/10/01
JO - Journal of cachexia, sarcopenia and muscle
DO - 10.1002/jcsm.70413
UR - https://europepmc.org/article/MED/42913715
AB - Background Loss of ambulation (LOA) is a key milestone in Duchenne muscular dystrophy (DMD) with highly variable timing, complicating clinical counselling and trial design. Quantitative MRI non-invasively assesses muscle fat infiltration, yet few models have integrated MRI with clinical variables for individualized LOA prediction. We aimed to develop and validate a machine-learning model integrating quantitative MRI and clinical features to predict time to LOA and to derive interpretable, individualized risk estimates and candidate thresholds.Methods This prospective study enrolled 188 boys with DMD (median age 9.10 years). Quantitative MRI parameters (T1, T2, fat fraction [FF]) of 19 hip/thigh muscles and clinical variables were measured. Patients were randomly split into training (80%) and test (20%) sets. Feature selection used LASSO, Boruta and recursive feature elimination based on random survival forest (RSF). Three survival models were compared: RSF and a ridge-penalised Cox model (both integrating clinical and MRI-derived features) and a multivariable Cox model restricted to clinical variables. Performance was assessed by concordance index (C-index), time-dependent area under the curve (AUC), integrated Brier score (IBS) and decision curve analysis at 12, 24, 36 and 48 months.Results Over median 43.5 months follow-up, 66 patients (35.1%) experienced LOA. Six predictors were retained: NSAA score, MRC%, age and three FF parameters (rectus femoris, vastus lateralis, obturator internus). In the test set (n = 40, 15 events), RSF achieved a C-index of 0.870 (95% CI, 0.764-0.957), outperforming the clinical Cox (0.804) and ridge Cox (0.853) model. Time-dependent AUCs of the RSF model were 0.984, 0.971, 0.913 and 0.850 at 12, 24, 36 and 48 months. RSF showed the best calibration, with the lowest IBS (0.076, 95% CI: 0.052-0.111), followed closely by the ridge Cox model (0.078) and the clinical Cox model (0.109). RSF stratified patients into low-risk, intermediate-risk and high-risk groups; no LOA events occurred in the low-risk group, with annual event rates were 7.2% and 34.6% in the intermediate- and high-risk groups (log-rank p = 0.0025). SHAP analysis identified exploratory thresholds (NSAA < 14.55, MRC% < 68.36%, rectus femoris FF > 32.30%, vastus lateralis FF > 58.00%, obturator internus FF > 7.43%). An interactive web application enables individualized risk prediction (https://westcndmd-timer-loa-risk-prediction-tool-8cygtrrbykvd9snmfcnhrp.streamlit.app/).Conclusions A machine-learning-based RSF model integrating quantitative MRI FF metrics and clinical variables exhibited favourable predictive performance for time to LOA in DMD across short- and long-term horizons. It provided interpretable, individualized risk estimates and was deployed as an online tool to support clinical decision-making and trial enrichment.
SN - 2190-5991
SN - 2190-6009
ER -